Cerebrocrast
Alternative Names: IOS 11212Latest Information Update: 25 Sep 2000
At a glance
- Originator Nonindustrial source
- Class Antihyperglycaemics; Neuroprotectants; Nootropics
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral vasospasm; Cognition disorders
Most Recent Events
- 25 Sep 2000 No-Development-Reported for Cerebral vasospasm in Latvia (IV)
- 25 Sep 2000 No-Development-Reported for Cognition disorders in Latvia (Unknown route)
- 16 Jun 1997 Phase-I clinical trials for Cerebral vasospasm in Latvia (IV)